PLGA:poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors

European Journal of Pharmaceutical Sciences

Volumn 41, Issue 5, 2010, Pages 644-649

  Parajó, Yolanda ^a   d'Angelo, Ivana ^a   Horváth, Aniko ^b   Vantus, Tibor ^b   György, Kéri ^b   Welle, Alexander ^c   Garcia Fuentes, Marcos ^a   Alonso, Maria Jose ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

Angiogenesis; Microparticles; Nanoparticles; PLGA; Poloxamer; Synthetic proangiogenic molecule; Tissue engineering

Indexed keywords

ANGIOGENIC FACTOR; DRUG CARRIER; NANOPARTICLE; POLOXAMER; POLYGLACTIN; SHA 2 22; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG STRUCTURE; ENCAPSULATION; MOLECULE; PARTICLE SIZE; POWDER; PRIORITY JOURNAL; REGENERATIVE MEDICINE; TISSUE ENGINEERING;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; CELL LINE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; LACTIC ACID; NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; PARTICLE SIZE; POLOXAMER; POLYGLYCOLIC ACID; TISSUE ENGINEERING;

EID: 78349305993     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2010.09.008     Document Type: Article

References (32)

1. Babensee J.E., Mcintire L.V., Mikos A.G. Growth factor delivery for tissue engineering. Pharm. Res. 2000, 17:497-504.
2. Bilati U., Allémann E., Doelker E. Strategic approaches for overcoming peptide and protein instability within biodegradable nano- and microparticles. Eur. J. Pharm. Biopharm. 2005, 375-388.
3. Blanco D., Alonso M.J. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. Eur. J. Pharm. Biopharm. 1998, 45:285-294.
4. Boontheekul T.J., Mooney D.J. Protein-based signaling systems in tissue engineering. Curr. Opin. Biotechnol. 2003, 14:559-565.
5. Borselli C., Ungaro F., Olimpia Oliviero O., d'Angelo I., Quaglia F., La Rotonda M.I., Netti P.A. Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres. J. Biomed. Mater. Res. A 2010, 94-102.
6. Cao Y., Hong A., Schulten H., Post M.J. Update on therapeutic neovascularization. Cardiovasc. Res. 2005, 65:639-648.
7. Carrasquillo K.G., Stanley A.M., Aponte J.C. Non-aqueous encapsulation of excipient-stabilized spray freeze-dried BSA into poly(lactide-co-glycolide) microspheres results in release of native protein. J. Control. Release 2001, 76:199-208.
8. Csaba N., Gonzalez L., Sánchez A., Alonso M.J. Design and characterisation of new nanoparticulate polymer blends for drug delivery. J. Biomater. Sci. Polym. Ed. 2004, 15(9):1137-1151.
9. Csaba N., Caamaño P., Sánchez A., Domínguez F., Alonso M.J. PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. Biomacromolecules 2005, 6:271-278.
10. Csaba N., Sánchez A., Alonso M.J. PLGA:poloxamer and PLGA:poloxamine blend nanostructures as carriers for nasal gene delivery. J. Control. Release 2006, 113:164-172.
11. d'Angelo I., Parajó Y., Horváth A., Kéri G., La Rotonda M.I., Alonso M.J. Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro and nanoparticles. J. Microencapsul. 2010, 27(1):57-66.
12. Elisseeff J., McIntosh W., Fu K., Blunk B.T., Langer R. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J. Orthop. Res. 2001, 19:1098-1104.
13. Horváth A., Seprödi J., Vantus T., Idei M., Bökönyi G., Tóvari J., Kenessey I., Keri G. Effect of new synthetic peptides and peptidomimetics on angiogenesis. Peptide Science 2006 (43rd Japanese Peptide Symposium and 4th Peptide Engineering International Conference) 2006, 249-250.
14. Horváth, A., Kéri, G., Tóvária, J., Seprödi, J., Vántus, T., Kenessey, I., Idei, M., Tanai, G.S., 2008a. Peptides for activation of angiogeneseis, pharmaceutical compounds containing sanam and use of these compounds. WO/2008/05016.
15. Horvath A., Knedlitschek G., Okada Y., Miyazaki A., Vantus T., Seprodi J., Varga A., Tanai H., Bokonyi G., Hiebl B., Keri G. Synthesis and biological evaluation of novel peptides influencing angiogenesis. J. Pept. Sci. 2008, 14(S1):126-127.
16. Kang S.W., Lim H.W., Seo S.W., Jeon O., Lee M., Kim B.S. Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. Biomaterials 2008, 29:1109-1117.
17. Kelm J.M., Diaz Sanchez-Bustamante C., Ehler E., Hoerstrup S.P., Djonov V., Ittner L., Fussenegger M. VEGF profiling and angiogenesis in human microtissues. J. Biotechnol. 2005, 118:213-229.
18. Mundargi R.C., Babu V.R., Rangaswamy V., Patel P., Aminabhavi T.M. Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives. J. Control. Release 2008, 125:193-209.
19. Nomi M., Atala A., De Coppi P., Soker S. Principals of neovascularization for tissue engineering. Mol. Aspects Med. 2002, 23:463-483.
20. Richardson T.P., Peters M.C., Ennett A.B., Mooney D.J. Polymeric system for dual growth factor delivery. Nat. Biotechnol. 2001, 19:1029-1034.
21. Sánchez A., Villamayor B., Guo Y., McIver J., Alonso M.J. Formulation strategies for the stabilization of tetanus taxoid in poly(lactide-co-glycolide) microspheres. Int. J. Pharm. 1999, 185:255-266.
22. Sánchez A., Tobio M., González L., Fabra A., Alonso M.J. Biodegradable micro- and nanoparticles as long-term delivery vehicles for interferon-alpha. Eur. J. Pharm. Sci. 2003, 18:221-229.
23. Santander-Ortega M.J., Jódar-Reyes A.B., Csaba N., Bastos-González D., Ortega-Vinuesa J.L. Colloidal stability of Pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. J. Colloid Interface Sci. 2006, 302:522-529.
24. Santander-Ortega M.J., Bastos-Gonzalez D., Ortega-Vinuesa J.L., Alonso M.J. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization. J. Biomed. Nanotechnol. 2009, 5(1):45-53.
25. Santander-Ortega M.J., Csaba N., González L., Bastos-González D., Ortega-Vinuesa J.L., Alonso M.J. Protein-loaded PLGA-PEO blend nanoparticles: encapsulation, release and degradation characteristics. Colloid Polym. Sci. 2010, 288:141-150.
26. Schoenhammer K., Boisclair J., Schuetz H., Petersen H., Goepferich A. Biocompatibility of an injectable in situ forming depot for peptide delivery. J. Pharm. Sci. 2010, 99(10):4390-4399.
27. Soker S., Machado M., Atala A. Systems for therapeutic angiogenesis in tissue engineering. World J. Urol. 2000, 18:10-18.
28. Tayalia P., Mooney D.J. Controlled growth factor delivery for tissue engineering. Adv. Mater. 2009, 21:3269-3285.
29. Tobio M., Nolley J., Guo Y., McIver J., Alonso M.J. A novel system based on a Poloxamer/PLGA blend a tetanus toxoid delivery vehicle. Pharm. Res. 1999, 16(5):682-688.
30. Wei G., Lu L.F., Lu W.Y. Stabilization of recombinant human growth hormone against emulsification-induced aggregation by pluronic surfactants during microencapsulation. Int. J. Pharm. 2007, 338:125-132.
31. Wischke C., Schwendeman S.P. Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int. J. Pharm. 2008, 364(2):298-327.
32. Zhang H., Gao S. Temozolomide/PLGA microparticles and antitumor activity against Glioma C6 cancer cells in vitro. Int. J. Pharm. 2007, 329:122-128.